hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis

Molecular and Cellular Biology

Volumn 22, Issue 7, 2002, Pages 2255-2266

  Iervolino, Angela ^a   Santilli, Giorgia ^a   Trotta, Rossana ^a   Guerzoni, Clara ^a   Cesi, Vincenzo ^a   Bergamaschi, Anna ^a   Gambacorti Passerini, Carlo ^a   Calabretta, Bruno ^a   Perrotti, Danilo ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; INTERLEUKIN 3; MESSENGER RNA; MESSENGER RNA PRECURSOR; PROTEASOME; PROTEIN BCL X; UBIQUITIN;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOPLASM; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LEUKEMOGENESIS; MOUSE; MYELOPOIESIS; NONHUMAN; NORTHERN BLOTTING; NUCLEOCYTOPLASMIC TRANSPORT; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BIOLOGICAL TRANSPORT; CELL DIFFERENTIATION; CELL LINE; CELL NUCLEUS; CELL SURVIVAL; CYSTEINE ENDOPEPTIDASES; CYTOPLASM; FUSION PROTEINS, BCR-ABL; GENE EXPRESSION REGULATION, LEUKEMIC; GRANULOCYTES; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LEUKOPOIESIS; MICE; MULTIENZYME COMPLEXES; MUTATION; MYELOID PROGENITOR CELLS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; RIBONUCLEOPROTEINS; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED; UBIQUITIN;

ANIMALIA; EUKARYOTA; MURINAE;

EID: 0036124398     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.7.2255-2266.2002     Document Type: Article

References (62)

1. Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis: Protection is correlated with up regulation of Bcl-xL
2. Granulocytic differentiation of normal hematopoietic precursor cells induced by transcription factor PU.1 correlates with negative regulation of the c-myb promoter
3. Human hnRNP protein A1 gene expression. Structural and functional characterization of the promoter
4. Isolation of an active gene encoding human hnRNP protein A1. Evidence for alternative splicing
5. Modulation of exon skipping by high-affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization
6. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
7. RNA binding specificity of hnRNP A1: Significance of hnRNP A1 high-affinity binding sites in pre-mRNA splicing
8. Interaction of hnRNP A1 with snRNPs and pre-mRNAs: Evidence for a possible role of A1 RNA annealing activity in the first steps of spliceosome assembly
9. hnRNP A1 selectively interacts through its Gly-rich domain with different RNA-binding proteins
10. An intron element modulating 5′ splice site selection in the hnRNP A1 pre-mRNA interacts with hnRNP A1
11. Phosphorylation of human hnRNP protein A1 abrogates in vitro strand annealing activity
12. Connections between the processing and nuclear export of mRNA: Evidence for an export license?
13. Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway
14. hnRNP A1 recruited to an exon in vivo can function as an exon splicing silencer
15. BCR-ABL down-regulates the DNA repair protein DNA-PKcs
16. hnRNP proteins and the biogenesis of mRNA
17. IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line
18. The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage
19. Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression
20. Sensitivity of the abl inhibitor STI571 in fresh leukaemic cells obtained from chronic myelogenous leukaemia patients in different stages of the disease
21. Growth factor independence and BCR/ABL transformation: Promise and pitfalls of murine model systems and assays
22. Biological consequences of the BCR/ABL fusion gene in humans and mice
23. Association of heterogeneous nuclear ribonucleoprotein A1 and C proteins with reiterated AUUUA sequences
24. Enhanced stability of interleukin-2 mRNA in MLA 144 cells. Possible role of cytoplasmic AU-rich sequence-binding proteins
25. Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL
26. Regulation of in vitro nucleic acid strand annealing activity of heterogeneous nuclear ribonucleoprotein protein A1 by reversible phosphorylation
27. A role for the M9 transport signal of hnRNP A1 in mRNA nuclear export
28. Regulation of Ich-1 pre-mRNA alternative splicing and apoptosis by mammalian splicing factors
29. Chronic myelogenous leukemia: A concise update
30. Pre-mRNA splicing imprints mRNA in the nucleus with a novel RNA-binding protein that persists in the cytoplasm
31. hnRNP complexes: Composition, structure, and function
32. Isolation of a recombinant copy of the gene encoding C/EBP
33. A protein that shuttles between the nucleus and the cytoplasm is an important mediator of RNA export
34. c-myc and c-myb protein degradation: Effect of metabolic inhibitors and heat shock
35. Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt
36. Heterogeneous ribonucleoprotein A1 is part of an exon-specific splice-silencing complex controlled by oncogenic signaling pathways
37. Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2
38. A nuclear export signal in hnRNP A1: A signal-mediated, temperature-dependent nuclear protein export pathway
39. The K nuclear shuttling domain: A novel signal for nuclear import and nuclear export in the hnRNP K protein
40. Identification of heterogeneous ribonucleoprotein A1 as a novel substrate for protein kinase C zeta
41. Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate
42. The hnRNP C proteins contain a nuclear retention sequence that can override nuclear export signals
43. Chronic myelogenous leukemia
44. Production of high-titer helper-free retroviruses by transient transfection
45. TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis
46. BCR-ABL prevents c-jun-mediated and proteasome-dependent FUS (TLS) proteolysis through a protein kinase CbetaII-dependent pathway
47. Shuttling of pre-mRNA binding proteins between nucleus and cytoplasm
48. Transcription-dependent and transcription-independent nuclear transport of hnRNP proteins
49. A novel receptor-mediated nuclear protein import pathway
50. CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors
51. The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation
52. TLS-CHOP and the role of RNA-binding proteins in oncogenic transformation
53. Chronic myeloid leukemia
54. The double lives of shuttling mRNA binding proteins
55. Transportin-mediated nuclear import of heterogeneous nuclear RNP proteins
56. PU.1 (Spi-1) and C/EBP alpha regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells
57. General RNA binding proteins render translation cap dependent
58. C/EBPalpha bypasses granulocyte colony-stimulating factor signals to rapidly induce PU.1 gene expression, stimulate granulocytic differentiation, and limit proliferation in 32D cl3 myeloblasts
59. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice
60. A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP
61. A topogenic role for the oncogenic N-terminus of TLS: Nucleolar localization when transcription is inhibited
62. TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling